TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 NOK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
0
|
0
|
819 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-193
|
-327
|
97 |
| EBITDA |
-193
|
-327
|
97 |
| Total assets |
151
|
251
|
606 |
| Current assets |
151
|
251
|
606 |
| Current liabilities |
69
|
78
|
117 |
| Equity capital |
80
|
170
|
487 |
| - share capital |
150
|
149
|
145 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
53.0%
|
67.7%
|
80.4% |
| Turnover per employee |
0
|
0
|
819 |
| Profit as a percentage of turnover | 11.8% | ||
| Return on assets (ROA) |
-127.8%
|
-130.3%
|
16.0% |
| Current ratio |
218.8%
|
321.8%
|
517.9% |
| Return on equity (ROE) |
-241.2%
|
-192.4%
|
19.9% |
| Change turnover |
0
|
-837
|
-121 |
| Change turnover % |
-100%
|
-13% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.